Bressi Jerome Charles bought FATE
January 15, 2025 · Form 4 insider transaction
Bressi Jerome Charles bought 65,000 shares of Fate Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
65,000
Price
$0.00
Total value
N/A
InsiderBressi Jerome Charles
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 15, 2025
Filing dateJanuary 16, 2025
Shares owned after335,203
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2026, January 8, 2027, January 8, 2028 and January 8, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.